Vasa Denticity Limited

As of March 31, 2026, Vasa Denticity Limited carries a market capitalization of 5.84B, placing it among publicly traded companies globally. Its enterprise value stands at 5.38B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Vasa Denticity Limited has 17.34M shares outstanding.

As of March 31, 2026, Vasa Denticity Limited trades at a trailing price-to-earnings ratio of 94.42. The price-to-sales ratio is 3.95, and the price-to-book ratio stands at 3.36.

As of March 31, 2026, Vasa Denticity Limited trades at an EV/EBITDA multiple of 87.79 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.68 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 107.63 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 5.38B versus a market cap of 5.84B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Vasa Denticity Limited maintains a current ratio of 8.01, meaning it holds 8.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.07, indicating conservative leverage, while an interest coverage ratio of 256.53 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Vasa Denticity Limited posted a return on equity (ROE) of 3.99, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 2.49 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.51, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 4.11, useful for judging operating efficiency across full business cycles. The company generates approximately 4.12M in revenue per employee across its workforce of 355.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.55 indicates how many times Vasa Denticity Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Vasa Denticity Limited recorded 17.49M in income tax expense. That works out to an effective tax rate of 22.87, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 76.46M, leaving 61.17M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Vasa Denticity Limited's stock has declined approximately 24.69% over the past 52 weeks. The 50-day moving average sits at 421.95, while the 200-day moving average is 436.88.

Over the twelve months ended March 31, 2026, Vasa Denticity Limited generated 1.46B in revenue and converted that into 61.17M in net income, yielding earnings per share of 3.44. EBITDA reached 61.31M, while operating income came in at 50.01M.

As of March 31, 2026, Vasa Denticity Limited holds 472.69M in cash and equivalents against 1.21M in total debt, resulting in a net debt position of -46.76M. Total book value stands at 1.74B, with working capital of 1.46B providing operational flexibility.

Over the twelve months ended March 31, 2026, Vasa Denticity Limited posted a gross margin of 28.41, reflecting its pricing power and cost economics. The operating margin of 3.42 and net profit margin of 4.18 provide insight into operational efficiency.

As of March 31, 2026, Vasa Denticity Limited has an Altman Z-Score of 18.05, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.